ATE449171T1 - Reagentia und verfahren zum nachweis von brustkrankheiten - Google Patents

Reagentia und verfahren zum nachweis von brustkrankheiten

Info

Publication number
ATE449171T1
ATE449171T1 AT97938467T AT97938467T ATE449171T1 AT E449171 T1 ATE449171 T1 AT E449171T1 AT 97938467 T AT97938467 T AT 97938467T AT 97938467 T AT97938467 T AT 97938467T AT E449171 T1 ATE449171 T1 AT E449171T1
Authority
AT
Austria
Prior art keywords
breast
diseases
useful
tissue
reagentia
Prior art date
Application number
AT97938467T
Other languages
English (en)
Inventor
Patricia Billing-Medel
Maurice Cohen
Tracey Colpitts
Paula Friedman
Julian Gordon
Edward Granados
Steven Hodges
Michael Klass
Jon Kratochvil
Lisa Roberts-Rapp
John Russell
Steven Stroupe
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Priority claimed from PCT/US1997/014665 external-priority patent/WO1998007857A1/en
Application granted granted Critical
Publication of ATE449171T1 publication Critical patent/ATE449171T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97938467T 1996-08-19 1997-08-19 Reagentia und verfahren zum nachweis von brustkrankheiten ATE449171T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69710596A 1996-08-19 1996-08-19
US08/912,276 US6183952B1 (en) 1996-08-19 1997-08-15 Reagents and methods useful for detecting diseases of the breast
PCT/US1997/014665 WO1998007857A1 (en) 1996-08-19 1997-08-19 Reagents and methods useful for detecting diseases of the breast

Publications (1)

Publication Number Publication Date
ATE449171T1 true ATE449171T1 (de) 2009-12-15

Family

ID=24799819

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938467T ATE449171T1 (de) 1996-08-19 1997-08-19 Reagentia und verfahren zum nachweis von brustkrankheiten

Country Status (3)

Country Link
US (1) US6183952B1 (de)
AT (1) ATE449171T1 (de)
DE (1) DE69739653D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138384B1 (en) * 1997-08-29 2006-11-21 The Regents Of The University Of California Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
IL156752A0 (en) * 2001-01-06 2004-02-08 Gen Hospital Corp Gene for identifying individuals with familial dysautonomia
US20030013145A1 (en) * 2002-08-12 2003-01-16 Ted Titmas Personal breast cancer indicator
US7094879B2 (en) 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
WO2007129628A1 (ja) * 2006-05-02 2007-11-15 Wako Pure Chemical Industries, Ltd. マイコバクテリウム・イントラセルラーレ検出用プライマー及びプローブ、並びにこれを用いたマイコバクテリウム・イントラセルラーレの検出方法
KR100803055B1 (ko) * 2006-11-03 2008-02-18 한국과학기술원 구면베어링 조립체의 제조장치 및 그 제조방법
GB201018096D0 (en) * 2010-10-27 2010-12-08 Binding Site Group The Ltd Coated beads

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2248136A1 (en) 1996-03-21 1997-09-25 Human Genome Sciences, Inc. Human endometrial specific steroid-binding factor i, ii and iii

Also Published As

Publication number Publication date
US6183952B1 (en) 2001-02-06
DE69739653D1 (de) 2009-12-31

Similar Documents

Publication Publication Date Title
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
Mitchell et al. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum.
WO2000055180A3 (en) Human lung cancer associated gene sequences and polypeptides
WO2001055343A8 (en) Nucleic acids, proteins, and antibodies
ATE318314T1 (de) Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens
DK0912738T3 (da) Antigen-bindende-fragmenter der specifikt detekterer cancerceller, nukleotider der koder fragmenterne og anvendelse deraf til profylakse og detektion af cancere
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
DE69839123D1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
ATE463508T1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
ATE405649T1 (de) Hemmstoff zur diagnose und behandlung von haemophilia a patienten
WO1999031274A3 (en) Reagents and methods useful for detecting diseases of the pancreas
WO2000041516A3 (en) Reagents and methods useful for detecting diseases of the breast
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
DE60121735D1 (de) Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen
DE69531167D1 (de) Verfahren zum nachweis und therapie von schuppenartigen zellkarzinomen und blasen-karzinomen insbesondere zur bestimmung der anwesenheit und behandlung von minimalen resterkrankungen, micrometastasierung oder der verbreitung von solchen karzinomtypen
DE60018964D1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
WO1999014357A3 (en) Reagents and methods useful for detecting diseases of the prostate, breast and ovary
WO2001055300A8 (en) Nucleic acids, proteins, and antibodies
DE602004006566D1 (de) Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung
WO2001055313A3 (en) Nucleic acids, proteins, and antibodies
DE60221698D1 (de) Nukleares protein "shoca" - eine komponente des wnt signaltransduktionsweges

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties